Back to Article List

FDA denies petition for qualified health claim for D-tagatose and reduced risk of type II diabetes


Feb 27, 2024

In relation to a petition received for a Qualified Health Claim for D-Tagatose, FDA has concluded that, based on scientific evidence and other information submitted by the petitioner, there is no credible evidence to support the claim for D-tagatose intake and reduced risk of type 2 diabetes. The petition has been denied.

For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox